NASDAQ · Biotechnology · USD
Yarrow Bioscience Inc (YARW) Stock Analysis
Yarrow Bioscience Inc (YARW) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
YARW Key Statistics
As of Oct 21, 2026Trading
- Open
- $20.33
- Previous Close
- $20.21
- Day's Range
- 19.77–20.33
- 52-Week Range
- 16.05–46.95
- Volume
- 73.50K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.08
Valuation
- Market Cap
- $187.67M
Financials (FY)
- Shares Outstanding
- 9.30M
- 1-Year Return
- +96.88%
Dividend and dates
- Ex-Dividend Date
- July 24, 2026
- Avg Volume
- 94.68K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, YARW closed at $20.17, +96.88% over 1 year.
Yarrow Bioscience Inc (YARW) has a market capitalization of $187.67M.
YARW Stock Return by Calendar Year
Yarrow Bioscience Inc (YARW) return since Jan 2018: what $10,000 became
- 1 year
- $10,000 $19,688
- +96.88%
- 5 years
- $10,000 $342
- −96.58%
- Since Jan 2018
- $10,000 $3
- −99.97%
If you had invested $10,000 in Yarrow Bioscience Inc (YARW) at the close on January 25, 2018, the earliest close on record here, it would have been worth $3 at the close on October 21, 2026: −99.97% in total, −59.84% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +23.22% |
| 2025 | −82.69% |
| 2024 | +43.78% |
| 2023 | −13.70% |
| 2022 | −85.29% |
| 2021 | −83.86% |
| 2020 | −65.95% |
| 2019 | +12.62% |
| 2018 | −85.65% |
As of October 21, 2026.
Recent News
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
YahooReported Earlier, Yarrow Bioscience Prices $150M Underwritten Public Offering Of 5,769,231 Shares At $26.00 Per Share
BenzingaYarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
YahooYarrow Bioscience Announces Proposed Underwritten Public Offering
YahooYarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed
BenzingaYarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate
Benzinga
All 8 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Biotechnology Stocks
Vertex Pharmaceuticals Incorporated
$132.95B
MRNAModerna, Inc.
$98.14B
REGNRegeneron Pharmaceuticals, Inc.
$82.95B
ARGXargenx SE
$55.97B
ONCBeOne Medicines AG
$43.97B
RVMDRevolution Medicines, Inc.
$41.64B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B